Jan. 13, 2023

The American College of Radiology’s® (ACR®) advocacy efforts to avoid or mitigate payment cuts resulting from a planned change to the Medicare conversion factor reclaimed (saved) $437 million in radiology reimbursement for 2023. In the last three years of fighting these scheduled payment reductions, this reclaimed reimbursement to radiology totaled more than $1.637 billion.

As previously reported in Advocacy in Action, Congress was unable to agree to stopping the full 8.5% adjustment for CY 2023 as urged by ACR and 100 other medical societies, but did mitigate 6.5% of that potential reduction by once again delaying the implementation of a 4% across-the-board cut statutorily mandated pay-as-you-go (PAYGO) provision and adding 2.5% to the 2023 Medicare conversion factor.

Despite the large amount reclaimed from planned cuts, the College and its physician and non-physician colleagues recognize that all stakeholders must continue to work with Congress to enact Medicare payment reform that avoids uncertainty due to such yearly payment fluctuations that neither political party desires.

For more information, please contact Josh Cooper, ACR Vice President, Government Relations.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more